CIK 0001326205 · Non-accelerated filer<br>Smaller reporting company
IGC Pharma, Inc.
Sign in to watch- Ticker
- IGC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MD
- Entity type
- operating
- EIN
- 202760393
- Phone
- 301-529-4996
- Business address
- 10224 FALLS ROAD, POTOMAC, MD, 20854
- Former names
- India Globalization Capital, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2008-03-20 | UBS AG 10% owner | Sale | −400 | $4.19 | $2K | 29,906 |
| 2008-03-20 | UBS AG 10% owner | Sale | −1,600 | $4.04 | $6K | 28,306 |
| 2008-03-20 | UBS AG 10% owner | Sale · Warrants (Right to Buy) | −360 | $0.60 | $216 | 1,016,285 |
| 2008-03-20 | UBS AG 10% owner | Sale · Warrants (Right to Buy) | −3,000 | $0.61 | $2K | 1,013,285 |
| 2008-03-20 | UBS AG 10% owner | Sale · Warrants (Right to Buy) | −8,200 | $0.60 | $5K | 1,005,085 |
| 2008-03-20 | UBS AG 10% owner | Sale · Warrants (Right to Buy) | −1,800 | $0.61 | $1K | 1,003,285 |
Page 31 of 31 · 606 trades